企業プロフィール

Forte Biosciences 株価・ニュース・カタリスト

ティッカー:
FBRX
取引所:
NASDAQ
セクター:
Biopharma
所在地:
United States

株価パフォーマンス

76.95 USD (+0.04%)

終値

最終更新: 2026年8月24日

372M USD

時価総額

株価変動の要因

As of Aug 24, 2026, FBRX was little changed and closed at $76.95. No new same-company headline was identified in the current news window.

企業概要

事業概要

Forte Biosciences is a clinical-stage biotechnology company focused on dermatology and immune-mediated disease. Its profile is built around translating immune and skin biology into differentiated therapies.

所在地とセクター分類

Forte is headquartered in the United States and listed on NASDAQ. It sits in specialty biotech with a dermatology and immunology focus.

ビジネスモデルの特徴

The company depends on clinical progress, dose selection, and pipeline prioritization to create value. Investors usually watch proof-of-concept data and whether the company can build a differentiated immune-dermatology franchise.

バイオ業界での位置付け

Forte occupies a small but catalyst-sensitive dermatology niche within biotech. The stock is typically driven by clinical updates and the market's view of the platform's differentiation.

今後のカタリスト

  • Forte Biosciences’ catalysts are FB-102 and any dermatology / immune-disease update that shows the program still has a strong path. The market will care about whether the next data point supports the platform thesis.

最近のニュース

    類似銘柄

    事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。